Device type · MTF
Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
MTF
Immunology
Device class
Class III
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
49
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
- Product code
- MTF
- Device class
- Class III
- Review panel
- Immunology
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for MTF
Latest FDA decisions
Siemens Healthcare Diagnostics, Inc.
P240021 · Decided Dec 3, 2025 · 531 days after receipt
Device type: Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer (MTF) · Laboratory Medicine & Pathology
P170037 · Decided Jan 30, 2019 · 449 days after receipt
Device type: Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer (MTF) · Laboratory Medicine & Pathology
Reports received
49
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
44
90% of reports
Injury reports
5
10% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 2 | 0 | 0 | 0 |
| Jan 24 | 4 | 0 | 0 | 0 |
| Feb 24 | 2 | 0 | 0 | 0 |
| Mar 24 | 3 | 0 | 0 | 0 |
| Apr 24 | 4 | 0 | 0 | 0 |
| May 24 | 1 | 0 | 0 | 0 |
| Jun 24 | 2 | 0 | 0 | 0 |
| Jul 24 | 4 | 0 | 0 | 0 |
| Aug 24 | 1 | 0 | 0 | 0 |
| Sep 24 | 2 | 0 | 0 | 0 |
| Oct 24 | 3 | 0 | 0 | 0 |
| Nov 24 | 2 | 0 | 0 | 0 |
| Dec 24 | 3 | 0 | 0 | 0 |
| Jan 25 | 1 | 0 | 0 | 0 |
| Feb 25 | 6 | 0 | 0 | 0 |
| Mar 25 | 5 | 0 | 0 | 0 |
| Apr 25 | 5 | 0 | 0 | 0 |
| May 25 | 12 | 0 | 0 | 0 |
| Jun 25 | 7 | 0 | 0 | 0 |
| Jul 25 | 6 | 0 | 0 | 0 |
| Aug 25 | 5 | 0 | 0 | 0 |
| Sep 25 | 1 | 0 | 0 | 0 |
| Oct 25 | 5 | 0 | 0 | 0 |
| Nov 25 | 7 | 0 | 0 | 0 |
| Dec 25 | 4 | 2 | 0 | 0 |
| Jan 26 | 3 | 0 | 0 | 0 |
| Feb 26 | 5 | 2 | 0 | 0 |
| Mar 26 | 2 | 0 | 0 | 0 |
| Apr 26 | 2 | 0 | 0 | 0 |
| May 26 | 3 | 0 | 0 | 0 |
| Jun 26 | 3 | 0 | 0 | 0 |
| Jul 26 | 3 | 0 | 0 | 0 |
| Aug 26 | 4 | 1 | 0 | 0 |
| Sep 26 | 6 | 0 | 0 | 0 |
| Oct 26 | 2 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Abbott17
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- High Test Results20
- Low Test Results20
- Non Reproducible Results11
4 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions45
- Insufficient Information4
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- IMMULITE 2000 PSA assay, Catalog Number L2KPTS2(D) (SMN 10706281) and Catalog Number L2KPTS6(D) (SMN 10706282)Open, Classified
Siemens Healthcare Diagnostics, Inc.
Z-0464-2025 · Started Sep 30, 2024 · Posted by FDA Nov 14, 2024
Reason given: The IMMULITE 2000 PSA assay for use on the IMMULITE 2000 and IMMULITE 2000 XPi analyzers did not meet the High-dose Hook Effect claim as stated in the Instructions for Use (IFU).
Cause as FDA categorized it: Under Investigation by firm
Siemens Healthcare Diagnostics, Inc.
Z-1119-2017 · Started Dec 21, 2016
Reason given: Negative bias with IMMULITE /IMMULITE 1000 Third Generation PSA (prostate-specific antigen) kit. The investigation by Siemens has confirmed that patient samples exhibit an average negative bias of approximately -22% with a range of -16% to -27% for samples recovering from 0.08 to 16.2 ng/mL.
Cause as FDA categorized it: Nonconforming Material/Component
Siemens Healthcare Diagnostics, Inc.
Z-1120-2017 · Started Dec 21, 2016
Reason given: Negative bias results with the IMMULITE /IMMULITE 1000 Third Generation PSA (prostate-specific antigen) kit was confirmed for two lots (D0119 and D0120). The investigation by Siemens has confirmed that patient samples exhibit an average negative bias of approximately -22% with a range of -16% to -27% for samples...
Cause as FDA categorized it: Nonconforming Material/Component
6 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.